Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060670 · ClinicalTrials.gov registry record · NA
A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
A NA study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 545
- Enrollment target
NCT01060670 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 545 participants.
The verdict
NCT01060670, a NA study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 545 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of the INTEGRA® Dermal Regeneration Template for the treatment of diabetic foot ulcers located distal to the malleolus in subjects with diabetes mellitus, neuropathy, and without significantly compromised arterial circulation.
Interventions
- DEVICE Integra® Dermal Regeneration Template
- OTHER Conventional Wound Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 545 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01060670
The ClinicalTrials.gov registry entry for NCT01060670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 545 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Integra® Dermal Regeneration Template is the first listed.
NCT01060670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01060670 about?
NCT01060670 is a clinical study titled "A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers". The objective of this study is to evaluate the safety and efficacy of the INTEGRA® Dermal Regeneration Template for the treatment of diabetic foot ulcers located distal to the malleolus in subjects with diabetes mellitus, neuropathy, and without significantly compromised arterial circulation.
What is the current status of trial NCT01060670?
This trial is currently completed. It is a NA study. The enrollment target is 545 participants. The study started on 2010-04. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01060670?
The interventions under investigation include: Integra® Dermal Regeneration Template (DEVICE), Conventional Wound Therapy (OTHER).
Who is sponsoring clinical trial NCT01060670?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.